![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
OPKO Health announced that the last patient has completed the final visit in the company’s pivotal phase 3 study evaluating the safety and efficacy of the once weekly somatrogon (hGH─CTP) for treatment of growth...
AstraZeneca presents strong Phase 3 Brilinta data for reducing CV risk
AstraZeneca has unveiled new positive Phase 3 data on the efficacy of Brilinta (ticagrelor) in combination with aspirin, showing that the therapy reduced the relative risk for the composite of cardiovascular (CV) death...
Roche’s flu drug Xofluza scores phase 3 primary endpoint
Demonstrates efficacy as a preventative treatment
Roche’s Tecentriq combo becomes first EU-approved immunotherapy for triple-negative breast cancer
Roche has announced the approval of Tecentriq (atezolizumab), in combination with Celgene’s chemotherapy drug Abraxane (nab paclitaxel), by the European Medicines Agency in the treatment of PD-L1-positive, unresectable...
4WEB Medical gets US FDA marketing nod for cervical spine truss system-stand alone interbody fusion device
4WEB Medical, an orthopedic device company focused on developing innovative implants utilizing its proprietary Truss Implant Technology, announced that the company has received 510(k) clearance from the US Food and Drug...
5 Actions Backed by Research to Improve Your Content Marketing
Now is a great time to evaluate your content marketing. If your program isn’t yet where you want it to be, now’s the time to start making some tweaks. Here’s a refresher of CMI’s 2019 research and resources to help...
26 onmisbare tools voor jou als contentspecialist
Je tovert met zinnen. Maakt content die aantrekkelijk en goed vindbaar is. En je inspireert collega’s om hetzelfde te doen. Dat is niet niks. Gelukkig zijn er tools die het je een stuk makkelijker maken. Bekijk en...
[column] MarketingTroonrede 2019: combineer purpose met perfecte klantervaring
Marketing is luisteren naar de markt en snel inspelen op de trends die je waarneemt. En als je de klant binnen hebt, zorgen dat hij blijft en jou aan anderen aanbeveelt. Hoe dan? Gerrit Piksen van SAMR Marktvinders...
Marketeers besteden video steeds meer uit
Meer dan een derde (37 procent) van de marketingprofessionals besteedt het merendeel van videoproductie uit. Met name voor de opname en montage van producties maken marketeers gebruik van een videospecialist. Slechts...
Researchers demonstrate the effectiveness of new bladder cancer treatment
Researchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute and doctors from Hospital del Mar, have demonstrated the effectiveness of a drug for treating metastatic bladder cancer in...
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
It’s no secret that the two existing PCSK9 cardiovascular drugs on the market, Amgen’s Repatha and Regeneron and Sanofi’s Praluent, are suffering from painfully slow launches. And on top of that, they could soon face a...
Uitgaven aan farmaceutische zorg stegen in 2018 met 1,1%
De uitgaven aan de farmaceutische zorg binnen het basispakket die via de openbare apotheken is geleverd, stegen in 2018 met € 47 miljoen tot € 4438 miljoen. Dat is een stijging van 1,1% ten opzichte van het jaar...
Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the...
Potential drug could revolutionize the treatment of neurological conditions
The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may prevent neuronal death through glucose metabolism...
AstraZeneca announces positive results from phase III ETHOS trial of triple-combo therapy Breztri Aerosphere to treat COPD
AstraZeneca announced positive results from the phase III ETHOS trial for triple─combination therapy Breztri Aerosphere, formerly PT010, in patients with moderate to very severe chronic obstructive pulmonary disease...
Bristol─Myers Squibb gets European nod for Empliciti plus pomalidomide & low─dose dexamethasone to treat MM
Bristol─Myers Squibb Company announced that the European Commission (EC) has approved Empliciti (elotuzumab) plus pomalidomide and low─dose dexamethasone (EPd) for the treatment of adult patients
US FDA approves Kyowa Kirin’s Nourianz tablets as new add─on drug to treat off episodes in adults with Parkinson’s disease
The US Food and Drug Administration (FDA) approved Nourianz (istradefylline) tablets as an add─on treatment to levodopa/ carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off”...
FDA warns three Hepatitis C drugs may worsen liver function in some rare cases
The FDA has warned that three Hepatitis C (HCV) drugs made by AbbVie, Gilead and MSD are worsening liver function and causing liver failure in some patients. The US regulator said it has identified 63 cases in which HCV...
